GERN Q1 2020 Earnings — Geron Corporation Revenue & Financial Results | Market Cap Arena

GERNGeron Corporation

$1B

Q1 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$52,000-8.8% YoY

Gross Profit

-$7M-12653.8% margin

Operating Income

-$17M-32442.3% margin

Net Income

-$16M-31451.9% margin

EPS (Diluted)

$-0.08

QoQ Revenue Growth

-69.6%

Cash Flow

Operating Cash Flow

-$26M

Free Cash Flow

-$26M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$143M

Total Liabilities

$22M

Stockholders' Equity

$121M

Cash & Equivalents

$20M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$52,000	$57,000	-8.8%
Gross Profit	-$7M	-$4M	-63.1%
Operating Income	-$17M	-$11M	-49.3%
Net Income	-$16M	-$10M	-62.6%